The Patent Finder

Hormos Medical Oy Ltd.

Also on record
Records under this name other than patents Hormos Medical Oy Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Hormos Medical Oy Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,642,079Solid Formulations of Ospemifene
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,236,861Method for Enhancing the Bioavailability of Ospemifene
Formerly held
Term ended
Term ended Aug 11, 2026 · High confidence
Term endedTerm ended Aug 11, 2026High confidence
US 6,245,819Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause
Formerly held
Term ended
Term ended Jul 21, 2025 · USPTO record
Term endedTerm ended Jul 21, 2025USPTO record
US RE47,316Oral formulations of ospemifene
Formerly held
Term ended
Term ended May 3, 2025 · USPTO record
Term endedTerm ended May 3, 2025USPTO record
US 8,470,890Method for Enhancing the Bioavailability of Ospemifene
Formerly held
Term ended
Term ended Feb 13, 2024 · High confidence
Term endedTerm ended Feb 13, 2024High confidence
US 8,772,353Method for Enhancing the Bioavalability of Ospemifene
Formerly held
Term ended
Ended no later than Feb 13, 2024 · Medium confidence
Term endedEnded no later than Feb 13, 2024Medium confidence
US 9,855,224Method for Enhancing the Bioavailability of Ospemifene
Formerly held
Term ended
Term ended Feb 13, 2024 · Medium confidence
Term endedTerm ended Feb 13, 2024Medium confidence
US 9,241,915Method for Enhancing the Bioavailability of Ospemifene
Formerly held
Lapsed on the fee record
Ended Jan 26, 2024 · Medium confidence
Lapsed on the fee recordEnded Jan 26, 2024Medium confidence
US 9,566,252Method for the alleviation of dyspareunia in women
Formerly held
Term ended
Term ended Nov 2, 2022 · USPTO record
Term endedTerm ended Nov 2, 2022USPTO record
US 6,984,665Methods for the Inhibition of Atrophy or for Treatment or Prevention of Atrophy-Related Symptoms in Women
Formerly held
Term ended
Term ended Jul 10, 2021 · Medium confidence
Term endedTerm ended Jul 10, 2021Medium confidence
10 of 22 patents shown.
Pro members see all 22.
Pro members: see all 22 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited